FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Epinephrine Injection, 0.1 mg/mL
Status: Discontinuation
»Therapeutic Categories: Cardiovascular; Pulmonary/Allergy

Hospira, Inc. (Revised 02/09/2017)

Company Contact Information:
877-946-7747

Presentation Posting Date Related Information
0.1mg/mL; 1 mg/10 mL LifeShield™ Abboject™ Glass Syringe (18 G x 3 1/2“) (NDC 0409-4901-18) 02/09/2017 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English